Aims-Animal studies have shown that antigens present within the gut play an important role in the development ofacute graft versus host disease (GvHD) following allogeneic bone marrow transplantation (BMT). In previous studies, inert sugars have been found to penetrate the small bowel mucosa after conditioning therapy for BMT; endotoxaemia can also occur during acute GvHD. Data on absorption of antigenic proteins across the gut following BMT in humans have not been presented as yet.
Enteric microbial antigens are thought to play a role in the development of acute graft versus host disease (GvHD) as has been shown in both animal experiments' and clinical studies.6
Antigens are thought to penetrate the mucosa following damage caused by conditioning therapy and sensitise donor lymphocytes to host antigens, enhancing the graft versus host reaction. Conditioning chemotherapy can damage the bowel mucosa for up to four weeks following transplantation, with acute GvHD also compromising barrier function.7 Indeed, we have shown previously that endotoxaemia is not unusual during acute GvHD.8
Absorption of tiny amounts of antigenic protein occurs in normal individuals and is thought to play an important role in the development of tolerance to gut derived antigens.9 The absorption of antigenic proteins is not well understood. Here, we describe the absorption of ovalbumin and endotoxin across the human small bowel mucosa following allogeneic bone marrow transplantation (BMT) at onset of acute GvHD.
Methods
The study population comprised patients entering the Bone Marrow Transplant Unit at the University Hospital of Wales, Cardiff . Patient details are presented in table 1.
All patients received the same conditioning therapy comprising cyclophosphamide 60 mg/ kg on two successive days followed by total body irradiation (1125 cGy given in five fractions over three days at a rate of 5 cGy/minute), were nursed in laminar flow rooms, and received gut decontamination therapy consisting of nystatin, amphotericin, colistin, and cotrimoxazole along with acyclovir. Initially, 18 patients were enrolled into the study but only six successfully completed the tests, almost entirely because of their refusal to repeat the ovalbumin test as this had a particularly bad taste and consistency. Lactulose/mannitol permeability tests and ovalbumin penetration studies were performed and plasma endotoxin/ antiendotoxin antibody concentrations determined before administration of conditioning therapy, at onset of GvHD and one day thereafter. 37°C and all tests were performed in triplicate. The ELISA could detect 0-01 ng/ml ovalbumin with an intraassay coefficient of variation of 5 9% (25 ng/ ml) and 6% (1-5 ng/ml) and an interassay coefficient of variation of 5-7% (25 ng/ml) and 7% (15 ng/ml).
DETERMINATION OF ANTIBODIES AGAINST OVALBUMIN
An ELISA plate was coated with ovalbumin (10 ng/ml) and incubated overnight at 4 'C. After washing three times (PBS/Tween), pooled human serum (diluted 1 in 100 in 1% BSA) was added to four wells as a standard. The patients' serum samples (diluted 1 in 10)
were then added in doubling dilutions (1 in 10 to 1 in 5120) and incubated for one hour at 37°C. After a further wash, antihuman IgG/ peroxidase (Sigma) (diluted 1 in 2000 in 0 1% BSA) was added to all wells for a further hour. A final wash was performed before the addition of orthophenylene diamine for 30 minutes; the reaction was stopped with 2 M sulphuric acid. Optical density was then measured at 492 nm.
A similar method was used to estimate antiovalbumin IgA, but in this instance the pooled human serum was diluted 1 in 10 and antihuman IgA (diluted 1 in 2000; Sigma) was used. The titre was defined as that concentration of patient serum which equaled half the maximum of pooled human serum antiovalbumin activity.
LACTULOSE/MANNITOL TEST
After an overnight fast, the patients emptied their bladders and then drank a solution comprising 5 g mannitol, 5 g lactulose and 65 ml water over five minutes. Urine was then collected over five hours. The patients were allowed to eat and drink two hours after starting the test. The total volume of urine passed was recorded and a 20 ml aliquot was taken and stored at -20°C until analysis was performed using the methods of Laker.101' The per cent excretion of both lactulose and mannitol was measured and the results expressed as a ratio of lactulose to mannitol (normal range <0.02). Mannitol (a monosaccharide, molecular weight 182, radius 0 4 nm) is passively absorbed transcellularly through aqueous pores in the epithelial cell membrane. A decrease in the urinary excretion of mannitol represents epithelial cell loss and a reduction in the cell surface area of the bowel (normal range of excretion 8-40%). Lactulose (a non-digestable disaccharide, molecular weight 342, radius 0-54 nm) is passively absorbed through the intercellular tight junctions and the villous tip extrusion zone. An increase in lactulose excretion represents damage to the tight junctions (normal range of excretion <0.3%).
Expression of lactulose and mannitol excretion as a ratio means that changes in bowel transit time, gastric emptying or renal function do not alter the overall result as each of the probe molecules will be similarly affected.
PLASMA ENDOTOXIN ASSAY
Endotoxin was determined using the limulus chromogenic substrate assay kit (Quadratech, Surrey, UK), adapted for use on a sterile microtitre plate. Absorption at 405 nm was read on an ELISA plate reader (Labsystems) and results converted into pg/ml endotoxin by linear regression analysis from standard curves generated with known endotoxin concentrations in standard plasma. This assay was found to be sensitive to less than 5 pg/ml, specific and reproducible (interassay coefficient of variation <5%).
ANTIENDOTOXIN ANTIBODY ESTIMATION
Antiendotoxin antibody estimation was performed using ELISA. Endotoxin antigens from Escherichia coli EH100, Salmonella minnesota Re595, Salmonella typhimurium SL684, and Shigella flexneri (all from Sigma) were mixed together to form a cocktail which was made up at 1 mg/ml in pyrogen free water. The cocktail was then diluted to 20 mcg/ml in 0 05 M sodium bicarbonate (pH 9-8) containing 0-02 M magnesium chloride, and 100 mcg of this solution was added per well to alternate rows of a 96-well plate (Dynatech) and left to coat overnight at room temperature. After washing the plates in PBS, containing 0-1% (v/v) Tween 20, 0 5% (w/v) sodium azide and 0-02 M magnesium chloride, remaining binding sites were blocked by post-coating in 1% BSA in pyrogen free PBS for one hour at 37 'C. Patients' serum was added to the plates in duplicate at a 1 in 100 dilution in wash buffer containing 4% polyethylene glycol 6000 (w/v) and 1% BSA. The test serum samples were compared with a control serum made from a pool of over 100 normal blood donors, matched for age and sex, which was added at dilutions from 1 in 25 to 
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